Slate Medicines, Inc. — Form D
Slate Medicines, Inc. of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2026-03-11. The offering totals $130.0M, of which $10.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2026-03-11
- Form: D
- Accession: 0001231919-26-000246
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $130.0M
- Amount sold: $10.0M
- Remaining: $120.0M
- Investors: 6
- Date of first sale: 2026-02-17
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-576090
Issuer
- Name: Slate Medicines, Inc.
- CIK: 0002117806
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2024
- Address: 200 BERKELEY STREET, 18TH FLOOR, BOSTON, MA, 02116
- Phone: (617) 778-2500
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Neil Buckley | Director | Boston, MA |
| Andrew Levin | Director | BOSTON, MA |
| Tim Lohoff | Director | Boston, MA |
| Cindy Xiong | Director | Boston, MA |
| Neil Buckley | Executive Officer | Boston, MA |
| Gregory Frank Oakes | Executive Officer | Boston, MA |
| Sara Pacheco | Executive Officer | Boston, MA |
More